// App-Quantinova.ai

10599 : Serum HER2 in the context of circulating tumor cells in patients with metastatic breast cancer.

Researchers

Presenter

  • Volkmar Mueller

Principal Investigators

  • Sabine Riethdorf

  • Brigitte Kathrin Rack

  • Wolfgang Janni

  • Peter A. Fasching

  • Erich Solomayer

  • Bahriye Aktas

  • Sabine Kasimir-Bauer

  • Klaus Pantel

  • Tanja N. Fehm

Medical Centers

  • Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Institute for Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Universitaetsklinikum Duesseldorf, Department of Gynecology and Obstetrics, Duesseldorf, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

  • Department of Obstetrics and Gynecology, University Erlangen, Erlangen, Germany

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Obstetrics and Gynecology, University of Goettingen, Goettingen, Germany

  • Department of Obstetrics and Gynecology, University Medical Center, Homburg/Saar, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved